My ePortfolio Register   

AACR 2014 /
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

5th - 9th Apr 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.05.14
Views: 1274
Rating:

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA

At a press conference during the AACR conference, Dr Daud discussed the biomarker which has been found which can help identify those melanoma patients who are most likely to respond to immunotherapy treatment MK-3475. 

Read the article for more.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence